Clinical Trials in Lethbridge, Alberta
8 recruiting
Showing 1–8 of 8 trials
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Crohn's Disease
Merck Sharp & Dohme LLC1,200 enrolled499 locationsNCT06430801
Recruiting
Pompe Disease Registry Protocol
Pompe DiseaseGlycogen Storage Disease Type II
Genzyme, a Sanofi Company2,000 enrolled272 locationsNCT00231400
Recruiting
Phase 3
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
Ischemic Stroke; Ischemic Attack, Transient
Janssen Research & Development, LLC15,000 enrolled880 locationsNCT05702034
Recruiting
Dialyzing Wisely - Improving the Delivery of Acute Renal Replacement Therapy to Albertans
Acute Renal Injury
University of Alberta4,500 enrolled15 locationsNCT05186636
Recruiting
Phase 3
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Primary Generalized Tonic-Clonic Seizures
Xenon Pharmaceuticals Inc.160 enrolled138 locationsNCT05667142
Recruiting
Not Applicable
Alberta Collaborative QI Strategies to Improve Outcomes of Moderate and Late Preterm Infants (ABC-QI Trial)
Length of Stay
University of Calgary9,500 enrolled12 locationsNCT05231200
Recruiting
Not Applicable
Optimizing the Management of Staphylococcus Aureus Bacteremia (OPTIMUS-SAB)
Staph Aureus Bacteremia
University of Alberta1,800 enrolled101 locationsNCT06338176
Recruiting
Not Applicable
Contingency Management as an Adjunct Treatment for Rural and Remote Disordered Gamblers
Gambling Disorder
University of Lethbridge54 enrolled1 locationNCT02953899